Genetic Analysis AS announces milestone in the IBD diagnostic test development project – completion of biomarker panel for GA-map® IBD Precision Dx
OSLO, NORWAY – 17 November 2025: Microbiome DX company Genetic Analysis AS (“GA”) is pleased to announce the completion of the biomarker panel development in its ongoing IBD Precision Dx…
Genetic Analysis AS launches the GA-map® MHI GutHealth reagent kit
OSLO, NORWAY – 24 September 2025: Microbiome DX company Genetic Analysis AS (“GA”) announces the launch of a novel Research Use Only (RUO) reagent kit, the GA-map® MHI GutHealth. The…
Publication of Half-year report 2025
OSLO, NORWAY – August 27 2025: Genetic Analysis AS (“GA” or the “Company”) hereby publishes the half-year report for H1, and April – June 2025. The Half-year report is available…
Genetic Analysis AS and Pangea Laboratory LLC announces the launch of GA-map® MHI GutHealth in the USA
OSLO, NORWAY/IRVINE, CA, USA – 29 July 2025: Microbiome DX company Genetic Analysis AS (“GA”) and Pangea Laboratory LLC (“Pangea”) announces the launch of the GA-map® MHI GutHealth as a…
Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises
Genetic Analysis AS’ (“GA” or the “Company”) subsequent offering to existing shareholders, for which the subscription period ended on June 16, 2025 (the “Subsequent Offering”), has now been registered with…
Genetic Analysis announces final outcome of the subsequent offering to existing shareholders
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA,…
Genetic Analysis: Direct issue has now been registered with the Norwegian Register of Business Enterprises
OSLO, NORWAY – June 18, 2025: Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) hereby announces that the direct issue which was announced in a press release on…
Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA,…
Genetic Analysis AS: Mandatory notification of trade
OSLO, NORWAY – 12 June 2025: Genetic Analysis AS (“GA” or “the Company”) announces that members of the Board and Management have subscribed for shares in the ongoing share offering…
Today is the last day for trading in the subscription rights for subscribing for shares in Genetic Analysis
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA,…
Today the subscription period in Genetic Analysis subsequent offering begins
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA,…
Genetic Analysis first day of trading excluding subscription rights
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA,…
Genetic Analysis publishes Simplified disclosure document relating to the previously announced subsequent offering
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA,…
Genetic Analysis Last day of trading including subscription rights
Oslo, Norway, June 2, 2025 – Genetic Analysis AS (“GA” or the “Company”) hereby announces that today, the 2nd of June, 2025, is the last day of trading including subscription rights…
Genetic Analysis announces details of Subsequent Offering following directed issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, SWITZERLAND, SINGAPORE, SOUTH KOREA, RUSSIA,…